Groowe Groowe / Newsroom / DRMA
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

DRMA News

Dermata Therapeutics, Inc. Common Stock

Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

accessnewswire.com
DRMA

Form 8-K

sec.gov
DRMAW DRMA

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026

accessnewswire.com
DRMA

Form 8-K

sec.gov
DRMAW DRMA

Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment

accessnewswire.com
DRMA

Form 8-K

sec.gov
DRMA DRMAW

Form 8-K

sec.gov
DRMA DRMAW

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026

accessnewswire.com
DRMA

Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System

accessnewswire.com
DRMA DRMAW

Form 8-K

sec.gov
DRMAW DRMA